SageMED

SageMED in Bellevue, Washington offers Spravato esketamine, an FDA-approved nasal spray for adults with treatment-resistant depression and major depressive disorder with suicidal thoughts or behavior, used alongside an oral antidepressant. Spravato targets the brain's glutamate system to support changes in connectivity associated with depression, working differently from standard antidepressants.

Spravato is administered in-office under the guidance of Dr. David Deichert, with a required two-hour observation period after each session during which patients can rest, listen to music, or use the clinic's Wi-Fi. Treatment typically begins twice weekly for the first four weeks, then tapers based on progress, and patients must arrange transportation home.

An integrative health clinic serving the Greater Seattle area, SageMED provides personalized planning and support throughout the treatment course in a private, comfortable setting.